Cargando…

Real-Life Anemia Management Among Patients with Non-Dialysis-Dependent Chronic Kidney Disease in Three European Countries

BACKGROUND: Anemia is prevalent among patients with chronic kidney disease (CKD), yet current evidence indicates that treatment may not adhere to Kidney Disease: Improving Global Outcomes (KDIGO) guidelines. We aimed to document the management of patients with non-dialysis-dependent (NDD)-CKD receiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fliser, Danilo, Mata Lorenzo, Maria, Houghton, Katherine, Ainsworth, Claire, Blogg, Martin, González de Antona Sánchez, Elena, Portoles, Jose
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108867/ https://www.ncbi.nlm.nih.gov/pubmed/37077414 http://dx.doi.org/10.2147/IJNRD.S401598

Ejemplares similares

Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis
por: Provenzano, Robert, et al.
Publicado: (2020)

Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies
por: Barratt, Jonathan, et al.
Publicado: (2023)

Effective Achievement of Hemoglobin Stability with Once-Monthly C.E.R.A. in Peritoneal Dialysis Patients: A Prospective Study
por: Koch, Michael, et al.
Publicado: (2013)

Vadadustat for treatment of anemia in patients with dialysis-dependent chronic kidney disease receiving peritoneal dialysis
por: Sarnak, Mark J, et al.
Publicado: (2023)

The Hannover Dialysis Outcome (HAN-D-OUT) study: comparison of standard versus intensified dialysis in treatment of patients with acute kidney injury in the ICU
por: Faulhaber-Walter, R, et al.
Publicado: (2008)

Retraction notice to “Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis.” Kidney Int Rep. 2021;6:613–623
por: Provenzano, Robert, et al.
Publicado: (2022)

The management of anemia in pediatric peritoneal dialysis patients: Guidelines by an ad hoc European committee
por: Schröder, Cornelis H.
Publicado: (2003)

Anemia in Chronic Kidney Disease: From Pathophysiology and Current Treatments, to Future Agents
por: Portolés, Jose, et al.
Publicado: (2021)

Assessing the Progression of Alzheimer’s Disease in Real-World Settings in Three European Countries
por: Lladó, Albert, et al.
Publicado: (2021)

Real-World Impact of Cardiovascular Disease and Anemia on Quality of Life and Productivity in Patients with Non-Dialysis-Dependent Chronic Kidney Disease
por: Covic, Adrian, et al.
Publicado: (2017)

A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines on Acute Kidney Injury: Part 1: definitions, conservative management and contrast-induced nephropathy(†)
por: Fliser, Danilo, et al.
Publicado: (2012)

Renal anemia and hydration status in non-dialysis chronic kidney disease: Is there a link?
por: Hildegard Stancu, Simona, et al.
Publicado: (2018)

A material stress test study on occurrence of leakage and material failure of peritoneal dialysis (PD) catheters
por: Klingele, Matthias, et al.
Publicado: (2021)

A real-world longitudinal study of anemia management in non-dialysis-dependent chronic kidney disease patients: a multinational analysis of CKDopps
por: Lopes, Marcelo Barreto, et al.
Publicado: (2021)

Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options
por: Jankowski, Joachim, et al.
Publicado: (2021)

Profile of peginesatide and its potential for the treatment of anemia in adults with chronic kidney disease who are on dialysis
por: Mikhail, Ashraf
Publicado: (2012)

Managing dialysis patients who develop anemia caused by chronic kidney disease: focus on peginesatide
por: Valliant, Amanda, et al.
Publicado: (2013)

Lessons learned from peginesatide in the treatment of anemia associated with chronic kidney disease in patients on dialysis
por: Kaushik, Tarun, et al.
Publicado: (2013)

Is hepcidin related with anemia and bone mineral metabolism in children with non-dialysis chronic kidney disease?
por: Yeşilbaş, Osman, et al.
Publicado: (2019)

Outcome of polycystic kidney disease patients on peritoneal dialysis: Systematic review of literature and meta-analysis
por: Dupont, Vincent, et al.
Publicado: (2018)

Anemia and clinical outcomes in patients with non-dialysis dependent or dialysis dependent severe chronic kidney disease: a Danish population-based study
por: Toft, Gunnar, et al.
Publicado: (2019)

Markers of cholesterol synthesis to cholesterol absorption across the spectrum of non‐dialysis CKD: An observational study
por: Emrich, Insa E., et al.
Publicado: (2021)

Effects of roxadustat on anemia, iron metabolism, and lipid metabolism in patients with non-dialysis chronic kidney disease
por: Hirai, Keiji, et al.
Publicado: (2023)

Association between anemia-related biomarkers and the adequacy of peritoneal dialysis in Chinese patients with chronic kidney disease
por: Li, Jia-Lin, et al.
Publicado: (2023)

Decreasing incidence of dialysis in older patients in The Netherlands as compared with other European countries: an international perspective
por: van Oevelen, Mathijs, et al.
Publicado: (2023)

Roxadustat for the Maintenance Treatment of Anemia in Patients with End-Stage Kidney Disease on Stable Dialysis: A European Phase 3, Randomized, Open-Label, Active-Controlled Study (PYRENEES)
por: Csiky, Botond, et al.
Publicado: (2021)

Changes in intraocular pressure after intravitreal fluocinolone acetonide (ILUVIEN): real-world experience in three European countries
por: Chakravarthy, Usha, et al.
Publicado: (2019)

Hookworm Anemia in a Peritoneal Dialysis Patient in China
por: Wu, Fuquan, et al.
Publicado: (2016)

Roxadustat for CKD-related Anemia in Non-dialysis Patients
por: Coyne, Daniel W., et al.
Publicado: (2020)

Molidustat for Japanese Patients With Renal Anemia Receiving Dialysis
por: Akizawa, Tadao, et al.
Publicado: (2021)

The development of anemia is associated to poor prognosis in NKF/KDOQI stage 3 chronic kidney disease
por: Portolés, José, et al.
Publicado: (2013)

Microcosting study of ICU costs in three European countries
por: Tan, SS, et al.
Publicado: (2008)

What should European nephrology do with the new CKD-EPI equation?
por: Gansevoort, Ron T, et al.
Publicado: (2022)

Desidustat in Anemia due to Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-D)
por: Gang, Sishir, et al.
Publicado: (2022)

A real-world prospective study on dialysis-requiring acute kidney injury
por: Gomes, Conrado Lysandro R., et al.
Publicado: (2022)

Once-Monthly Continuous Erythropoietin Receptor Activator (C.E.R.A.) in Patients with Hemodialysis-Dependent Chronic Kidney Disease: Pooled Data from Phase III Trials
por: Locatelli, Francesco, et al.
Publicado: (2016)

Cardiovascular and non-cardiovascular mortality in dialysis patients: where is the link?
por: Jager, Kitty J, et al.
Publicado: (2011)

Fatigue characteristics on dialysis and non-dialysis days in patients with chronic kidney failure on maintenance hemodialysis
por: Debnath, Subrata, et al.
Publicado: (2021)

Trends in anemia care in non-dialysis-dependent chronic kidney disease (CKD) patients in the United States (2006–2015)
por: Park, Haesuk, et al.
Publicado: (2018)

Hemoglobin targets for the anemia in patients with dialysis-dependent chronic kidney disease: a meta-analysis of randomized, controlled trials
por: Ye, Yuqiu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_g0hevh746mjhjfvgl4v22akau5